Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer (scientific article)

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Q29620301

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

Q33331108

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

Q33348775

Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical

Q35977580

Advances in intravesical therapy of urinary bladder cancer

Q35987762

Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum

Q37132088

A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study

Q37223381

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

Q37394447

An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer

Q37457872

Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.

Q44836588

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

Q46027726

Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.

Q47315054

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Q50512108

Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.

Q51062338

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

Q53263238

N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines

Q67983202

Bronchial response to oral versus aerosol metaproterenol in asthma

Q71388380

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

Q71791969

Inhalation of chemical substances and oxygen in radiotherapy of bronchial cancer

Q72121706

Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment

Q72725140

Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model

Q73025549

Inhaled steroids and the risk of hospitalization for asthma

Q73135833

High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma

Q73798145

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

Q74784116

Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung

Q80166992

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

platinum

doxorubicin

lung cancer

page(s)

2466-2473

P577

publication date

2010-04-06

P1433

published in

Clinical Cancer Research

Q332253

P1476

title

Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer

P478

volume

Reverse relations

cites work (P2860)

Q30448377	Clinical experimentation with aerosol antibiotics: current and future methods of administration
Q52714893	Comparison of quick recovery outcome of inhalable doxorubicin and cisplatin in lung cancer patients: a randomized, double-blind, single-center trial.
Q45035342	Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis.
Q28386699	Convergence of nanotechnology and cancer prevention: are we there yet?
Q36302124	Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer
Q40464067	Drug Delivery Devices for Inhaled Medicines.
Q33792946	Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution
Q38096410	Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology
Q36390679	Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
Q38689201	Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System
Q53234775	Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.
Q38925143	Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying
Q38971333	Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
Q47136450	In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.
Q92199483	Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer
Q92953557	Inhaled chemotherapy adverse effects: mechanisms and protection methods
Q38012447	Inhaled chemotherapy in lung cancer: future concept of nanomedicine
Q39360750	Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients
Q36132725	Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors
Q28393991	Magnetic core-shell nanoparticles for drug delivery by nebulization
Q38940456	Managing the oncologic patient with suspected pneumonia in the intensive care unit
Q53452247	Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization.
Q39192389	Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer.
Q58567874	POxylated Dendrimer-Based Nano-in-Micro Dry Powder Formulations for Inhalation Chemotherapy
Q57787012	Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac) in a Rodent Model
Q53533426	Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.
Q47106082	Protective efficacy of inhaled quercetin for radiation pneumonitis
Q50957929	Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Q53533414	Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.
Q39306543	Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Q47149508	Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro
Q92441132	Scaffold-based lung tumor culture on porous PLGA microparticle substrates
Q64119756	The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
Q37978509	Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery
Q51059658	Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer.
Q36321710	Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology

P356	DOI	10.1158/1078-0432.CCR-09-3015
P932	PMC publication ID	4262532
P698	PubMed publication ID	20371682